Indoxen (Indometacin)

Indometacin blocks both cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the production of prostaglandins—key mediators of inflammation, pain, and fever. Lower prostaglandin levels diminish swelling and pain at the affected site.

The exact dose and frequency of Indoxen are determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Dosage instructions are provided on the prescription label and should be followed precisely.

The safety of indometacin in pregnancy and lactation has not been fully established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To request Indoxen, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indoxen (indometacin) is a potent non‑selective NSAID, often considered more effective for certain acute gout attacks compared with ibuprofen or naproxen. However, its gastrointestinal and renal risk profile may be higher, so clinicians balance efficacy against safety when selecting therapy.

Indoxen suppositories should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Do not refrigerate or freeze the product, as temperature extremes can affect the suppository’s integrity.

Indoxen is supplied as a rectal suppository. The patient should insert the suppository gently into the rectum, preferably after a bowel movement, and remain lying down for a few minutes to ensure complete absorption.

Serious risks include gastrointestinal ulceration or bleeding, acute kidney injury, severe liver dysfunction, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored closely for any signs of these complications.

Indoxen is contraindicated in individuals with known hypersensitivity to indometacin or other NSAIDs, active gastrointestinal ulcer disease, severe renal or hepatic impairment, and in patients who have experienced serious cardiovascular events related to NSAID use.